Avoiding radiotherapy is an option for some older patients with breast cancer

Anastrozole cuts breast cancer cases by more than 50% in high risk women

Chemo-free treatment for acute promyelocytic leukaemia

NeoALTTO trial indicates breast cancer patients who had pathologic complete response had improved event-free and overall survival

Immune cells in tumours may identify breast cancer patients most likely to benefit from trastuzumab

BETH study: highly effective treatment option for patients with HER2 breast cancer

Screening mammography, over diagnosis and over treatment

2013 ecancermedicalscience article highlights

Initial phase III results of the first trial in newly diagnosed multiple myeloma

Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and IKZF3

Treating ALL patients with T cells targeted for CD19

Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies